In this work, two new photopharmacological ruthenium prodrugs are described that can be activated by green light. They are based on the tetrapyridyl biqbpy ligand (6,6 0 -bis[N-(isoquinolyl)-1-amino]-2,2 0 -bipyridine), which coordinates to the basal plane of the metal centre and leaves two trans coordination sites for the binding of monodentate sulphur ligands. Due to the distortion of the coordination sphere these trans ligands are photosubstituted by water upon green light irradiation. In vitro cytotoxicity data on A431 and A549 cancer cell lines shows an up to 22-fold increase in cytotoxicity after green light irradiation (520 nm, 75 J cm À2 ), compared to the dark control. Optical microscopy cell imaging and flow cytometry indicate that the cancer cells die via apoptosis. Meanwhile, very low singlet oxygen quantum yields ($1-2%) and cell-free DNA binding studies conclude that light-induced cell death is not caused by a photodynamic effect, but instead by the changes induced in the coordination sphere of the metal by light, which modifies how the metal complexes bind to biomolecules.
Introduction
Classical chemotherapy side effects are a burden for patients, limit treatment doses, and lower prognosis. Light-activated anti-cancer prodrugs have appeared as an alternate strategy to increase the selectivity of chemotherapeutic agents.
1 Ideally, their inactive form should minimally interact with biological molecules to limit the toxicity of the prodrug to non-irradiated tissues. Upon in vivo light irradiation these prodrugs are locally activated to selectively kill tumour cells. Among light-activated compounds those based on ruthenium(II) have been extensively studied due to their superior light absorption properties and rich photoreactivity. The majority of light-activated rutheniumbased anticancer compounds described to date belong to the class of photodynamic therapeutic agents (PDT agents) that generate singlet oxygen ( 1 O 2 ) as a means to locally kill cancer cells.
2 For example, clinical trials recently started with ruthenium-oligothiophene dyads TLD1411 and TLD1433, which are red-light activated, water-soluble, and resistant to photobleaching.
2c A less common family of ruthenium compounds consisting of photoactivated chemotherapy agents (PACT agents), where visible light excitation (350-800 nm) leads to the cleavage of a protecting group. This irreversible photoreaction releases a toxic ligand, 3 modies part of it, 4 or generates open coordination sites on the metal centre, which enables biological ligands to bind.
5 In PACT, a light-induced modication of the interaction between the metal compound and biological molecules triggers cell death.
3b, 4a,5a,6 The major advantage of this mode of activation, compared to PDT, is that it does not depend on the presence of molecular oxygen, and hence may be applied to treat hypoxic tumour tissues, a type of tumour tissue characterised by low response to standard chemotherapy and faster cancer progression.
7
Many ruthenium PACT agents known to date contain two bidentate ligands based on the 2,2 0 -bipyridine scaffold. 5a,8 Aer irradiation, bis-aqua photoproducts are formed with a cis conguration that mimic the binding pattern of cisplatin to DNA.
9 Transplatin, on the other hand, is not active in vivo and less cytotoxic than cisplatin in vitro, so that anticancer metallodrugs with a trans geometry, usually based on platinum(II), have not been considered until recently.
10 New trans platinum(IV) compounds have also been prepared as PACT agents that can be activated with UVA (320-400 nm) or high-energy visible light (400-450 nm).
5b,11 This type of light is, however, harmful to cells 12 and penetrates biological tissues sub-optimally. 13 We embarked on developing ruthenium-based PACT agents with a trans geometry that can be activated at higher wavelengths, i.e., closer to the phototherapeutic window.
, are based on a tetrapyridyl ligand (biqbpy) specically developed to coordinate in the basal plane of octahedral metal complexes and to leave two trans positions for the coordination of monodentate ligands.
15
In order to minimize interactions of the metal centre with biomolecules in the dark, sulphur-based monodentate ligands were selected, i.e., one dmso in [1]Cl, and two Amet À ligands in
[2]PF 6 , which can be removed by visible light irradiation. 16 The synthesis, photochemistry, and biological properties of these compounds are reported, which demonstrates that they can trigger apoptosis in human cancer cell lines upon green light irradiation. + (50% probability level) as observed in the crystal structure of ([1]Cl$MeOH) 2 . Chloride counter-anions, H atoms, lattice MeOH, and disorder, have been omitted for clarity. stable in the dark for 6 weeks (Fig. S4 †) . In pure DMSO, however, [2a] degraded over 16 h, also at À20 C (Fig. S6 †) . Thus, the dmso ligand was photosubstituted by water (Scheme 2). This reactivity is typical of geometrically distorted ruthenium(II) compounds that possess low-lying triplet metalcentred ( 3 MC) excited states with a strongly dissociative character.
Results and discussion

Synthesis and characterization
17 1 H NMR conrmed this analysis, as a new resonance at 2.72 ppm, characteristic of free dmso, appeared aer green light irradiation, but not in the dark (Fig. S16 †) . Similar evolutions were observed under blue light irradiation (450 nm, Fig. S10 and S11 †), which also allowed measuring a photosubstitution quantum yield (F PS ) of 0.3% (see ESI †). Overall, cleavage of the Ru-S bond of [1] + is a photochemical process, and compound (Photo)cytotoxicity studies
The cytotoxicity of compounds [1]Cl and [2]PF 6 was investigated against three cell lines, i.e., A549 (human adenocarcinoma human alveolar basal epithelial cells), A431 (human epidermoid carcinoma cells), and MRC-5 (noncancerous human foetal lung broblasts). The effective concentrations (EC 50 ), dened as the compound concentration that reduces cell viability by 50% compared to untreated wells, were measured, in the dark and aer light activation, following a protocol described in detail in Hopkins et al. 12a These studies aimed at establishing whether the photosubstitution reactions observed in a chemical environment may translate into in vitro light activation. Although both blue and green light resulted in photosubstitution, green light (520 nm) was chosen for the photocytotoxicity tests because it is much less toxic to human cell lines than blue light 12a and it penetrates further into biological tissues. Preliminary studies in a 96-well plate ( Fig. S14 and S15 †) demonstrated that in the conditions of our cell-irradiation setup (21 mW cm Table 1 . Although an identical dose of green light did not induce photocytotoxicity by itself (Fig. S23 †) , nor modify the cytotoxicity of cisplatin ( Fig. S24 and S25 
Light-induced apoptosis
To investigate which type of cell death occurred, the morphology of A549 cells was inspected in the dark and aer green light irradiation using bright eld microscopy (Fig. 3, S29 and 30 †). Directly aer irradiation (520 nm, 75 J cm À2 ), cells treated with [1]Cl (1.5 mM) displayed cell shrinkage, loss of cellcell contact, and membrane blebbing as depicted in Fig. 3b . An enhanced effect was detected when the cells were incubated for an additional 24 h aer light irradiation (Fig. 3d) . The changes in cell morphology are characteristic for apoptotic cell death.
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To conrm that a majority of the A549 cells treated with [1]Cl or [2]PF 6 and irradiated with green light died by apoptosis, their fate was investigated using the Annexin V-propidium iodide assay and analysed using ow cytometry (FC). The lack of cells in the top le quadrant indicates the absence of purely necrotic cells. Cells in the top right are commonly referred to as "secondary necrotic", and are a known artefact in in vitro assays.
According to the ow cytometry data, the photocytoxicity of [1]Cl and [2]PF 6 occurs via apoptosis without any sign of necrosis. In addition, confocal microscopy of A549 cells stained with tetramethylrhodamine ethyl ester (mitochondria) and DRAQ5 (nuclear DNA) showed that light irradiation diminished the mitochondrial membrane potential and induced chromosomal condensation, especially for [1]Cl (Fig. S31 †) . All of the tested cellular responses clearly demonstrate that compounds [1]Cl and [2]PF 6 belong to a rare sub-family of metallodrugs that can trigger apoptosis with green light.
Intracellular distribution and uptake
In order to gather information on the intracellular localisation of [1]Cl and [2]PF 6 , and to investigate whether the difference in cytotoxicity between [1]Cl and [2]PF 6 in the dark was due to differences in cell-uptake and/or of intracellular distribution, cell fractionation was performed. For this experiment, A549 cells were incubated with [1]Cl or [2]PF 6 for 6 h in the dark at concentrations corresponding to the EC 50 value. The cells were then harvested, the cytosol, membrane, nuclei, and cytoskeleton fractions were separated (see ESI †), and the ruthenium concentration in each fraction was measured by ICP-MS (Fig. S32 †) . The observed total uptake of [2]PF 6 (7.5 ng per 10 6 ) was signicantly lower compared to that of [1]Cl (16 ng/ 10 6 cells). As the effect of both treatments was identical (i.e., reducing the cell population by 50% (Fig. S34 †) . 25 In the dark, [1]Cl and [2]PF 6 have a low affinity and negligible association with any of the forms of the plasmid DNA.
In a second experiment, the ruthenium complexes and cisplatin were photolysed (l irr ¼ 520 nm) for different amounts of time (0-60 min) in the presence of pUC19 plasmid (Fig. 5) . For these experiments, a 50 : 1 BP : MC ratio was used, which displayed insignicant dark thermal binding. However, following green light irradiation complex [1]Cl showed signi-cant retardation of the SC form (Fig. 5a , lanes 5-9) compared to [2]PF 6 (Fig. 5b, lanes 5-9) , which itself showed slight changes in the OC and SC forms compared to the control. Additionally, a change in the intensity of the staining indicates that increased photoinduced binding of the metal complexes interferes with the intercalation of ethidium bromide. ) is somewhat higher compared to values published for other photoactivated ruthenium or trans-platinum complexes (typically 10 J cm À2 ). However, the green light used in this work (520 nm) is much less harmful to cells than the shorter wavelength (UV or blue light) reported previously, 4a,5b,12a,c,19a,27 so that high doses do not represent per se a problem. Green light also penetrates deeper into the skin, 28 which makes it more relevant for phototherapy.
Overall, the data presented in this article suggests that the activation mechanism for this new type of trans-ruthenium polypyridyl complexes relies on ligand photosubstitution reactions. The ruthenium species [2a] bound to two sulphur protecting ligands is the least cytotoxic, followed by the two monoprotected species [1a] 2+ a VIDI grant to S. B. Prof. E. Bouwman is kindly acknowledged for support and input. The COST action CM1105 "Functional metal complexes that bind to biomolecules" is gratefully acknowledged for stimulating scientic discussion.
